The effects of chronic exposure to the adenosine antagonist theophylline (Theo) and dibutyryl cyclic-AMP, a membrane-permeant derivative of the second messenger 3',5'-cyclic-AMP (cAMP), on contractions and adenosine receptor levels in cultured cardiocytes were studied. Binding of the Ai-adenosine receptor antagonist
INTRODUCTION
Adenosine acting at extracellular receptors modulates important physiological functions in the heart. The responses to adenosine include negative chronotropic, dromotropic and inotropic effects via Ai receptors, or vasodilatation via A 2 receptors /1-5/. In conditions of stress, such as hypoxia or ischemia, adenosine levels in the extracellular fluid of the heart rise dramatically. Activation of Ai-adenosine receptors is coupled to inhibition of adenylyl cyclase through a guanine nucleotide binding protein /6-13/, opening of K + channels /14-16/, and inhibition of Ca 2+ channels /17/. Because of these effects on cardiac function, adenosine analogs (agonists) can potentially be used as therapeutic agents /18/. Adenosine itself is widely used in the treatment of supraventricular tachycardia. Adenosine antagonists, such as theophylline, are commonly used for treating asthma and recently for treating myocardial ischemia /19,20/. The therapeutic effect of theophylline and other methylxanthines is partially mediated through antagonism of endogenous adenosine at its receptors.
Chronic exposure to theophylline or other methylxanthines has been shown to induce up-regulation of adenosine receptors in adipose tissue /21/ and brain /22-24Λ A significant increase in the density of Ai-adenosine receptors was observed in hearts of theophylline-fed animals /17,25/ and in membranes isolated from chick embryo heart cultures following theophylline treatment /26/. Since Theo also inhibits the activity of phosphodiesterases and could cause elevation of intracellular cAMP by either mechanism, we studied the effects of both Theo and cAMP on heart rate and adenosine receptor levels. Recently, we have shown that drug treatment which affected heart contractility in cardiocyte cultures regulated the density of Ai-adenosine receptors. In general, agents that accelerate heart rate, such as catecholamines or thyroid hormones, caused up-regulation of the receptors, whereas carbamylcholine, which attenuates the rate of contraction, reduced the density of A r adenosine receptors 121/. In the present study we have demonstrated that exposure of intact rat cardiocytes to theophylline or to cAMP, both of which accelerate heart rate, leads to up-regulation of cardiac Ai-adenosine receptors. Thus, present data further indicate that contractile activity regulates the density of A r adenosine receptors in the heart.
MATERIALS AND METHODS

Preparation of heart cell cultures
Rat hearts (1-2 days old) were removed under sterile conditions and washed 3 times in phosphate buffered saline (PBS) to remove excess blood cells. The hearts were minced to small fragments and then gently agitated in a solution of proteolytic enzyme-RDB (IIBR, Ness-Ziona, Israel) prepared from a fig tree extract. The RDB was diluted 1:50 in PBS, at 25°C for a few cycles of 10 min each, as described previously /27-30/. The supernatant suspensions containing dissociated cells, to which medium containing 10% horse serum (Biolab, Jerusalem, Israel) was added, were centrifuged at 150 g for 5 min. After centrifugation, the supernatant phase was discarded and cells were resuspended in high glucose (5 mg/ml) DMEM (Biological Industries, Kibbutz BeithHaemek, Israel) supplemented with 10% heat-inactivated horse serum and 2% chick embryo extract. The suspension of cells was diluted to lxlO 6 cells/ml and 1.5 ml were placed in 35 mm collagen-gelatincoated plastic culture dishes. Cultures were incubated in a humidified atmosphere of 5% CO2, 95% air at 37°C. Confluent monolayers, which exhibit spontaneous contractions, developed in culture within 2 days. The growth medium was replaced every 3-4 days.
Radioligand binding studies
Radioligand binding studies were carried out as described previously /27/. Washing of the intact cultures after Theo treatments was necessary to removed the antagonist, especially at high doses of Theo. Therefore, before the radioligand binding assay was done the cultures were washed six times, with an interval of 3-4 minutes between each washing. Intact cells were then incubated at room temperature (23-25°C) 
Protein content and creatine kinase activity
Protein determination was performed according to Bradford's method /31/, using bovine serum albumin as a standard.
The cardiocytes were washed with cold PBS, and the cells were homogenized in the same buffer. Creatine kinase activity was determined using a CK kit (Sigma, St. Louis, MO, USA), and the product of the enzymatic activity was measured spectrophotometrically at a wavelength of 340 nm as previously described 1211.
Measurement of contractility
Changes in the contractile state of individual cells in the cardiocyte monolayers were monitored using an optical video system. A 35 mm culture dish containing growth medium was placed in a chamber containing humidified atmosphere of 5% CO2, 95% air at 37°C. The chamber was placed on the stage of an inverted phase contrast microscope (Olympus). The cells were magnified with a 20x objective, and the image was captured by a television camera connected to a video motion detector that monitored cell movements. The analog voltage output from the motion detector was recorded (Graphtec Thermal Arraycorder WR 7500, Tokyo, Japan). For calculation of heart rate at least five cells from different culture-dishes were monitored.
Reproducibility of data
Each experiment was carried out at least in triplicate on sister cultures. Results are presented as means ± S.D. The significance of differences between the various treatments were analyzed using Student's t-test. Ρ < 0.05 was considered signficant.
Materials
Bradford solution for protein assay was purchased from Bio-Rad Lab (Munich, Germany). All other chemicals used were from Sigma Chemical Co. (St. Louis, MO, USA). [ 3 H]CPX (sp. act. 108.3 Ci/ mmol) was purchased from Dupont (Boston, MA, USA).
RESULTS
Effect of Theo on [ 3 H]CPX binding
Since Theo stimulates the contraction of cardiocytes, we investigated whether this increase in the rate of heart contraction is associated with a change in the level of adenosine receptors. As shown in Fig. 1, [ 3 H]CPX binding was significantly increased (P<0.05) in intact cardiocytes following 84 hours of 50 μΜ Theo treatment. An increase of 37% in the level of Ai-adenosine receptors was achieved following this treatment (Fig. 1 ). Scatchard analysis shows that the affinity of the Ai receptor for this antagonist remained nearly unchanged (Fig. IB) . Following this treatment there were no significant differences in protein content (1.13+0.11 mg/dish in control and 1.05+0.14 mg/dish in Theo) or in cell number. There were also no significant differences in protein content, cell number and creatine kinase activity between control and Theo (100 μΜ) following longer (5 day) treatment (Table 1) 
Coupling of adenosine receptor level to heart rate
Four day-old cardiocytes were treated with various concentrations of Theo for 5 days then heart rate (beats/min) and [ 3 H]CPX binding were measured. A linear correlation was found between the level of Ai-adenosine receptors and the heart rate at various Theo concentrations (Fig. 2) . Increases of 235, 138, 78 and 82% in Aiadenosine receptor levels against increases of 130, 66, 59, 63% in heart rate were obtained following treatment with 1000, 100, 10 and 1 μΜ of Theo, respectively (Fig. 2 ). There were no significant changes (78-85%) in [ 3 H]CPX binding, myocyte contractility and heart rate (54-60%) below 10 μΜ of Theo, although both parameters were elevated (Figs. 2 and 3) . 
Effects of exposure to a membrane-permeant cAMP derivative
Since Theo may cause an elevation of intracellular cAMP, the effects of treatment with this second messenger on adenosine receptor levels and on myocyte contractility were investigated. Direct application of dibutyryl-cAMP (cAMPdB) induced a significant increase in heart rate. Therefore, cardiocytes exposed chronically to this nucleotide were analyzed for heart rate and parameters of fmol/dish without a significant change in the affinity of the receptors for the radioligand (Fig. 4) . No significant difference in protein content, creatine kinase activity or in cell number was observed following this treatment; however, myocyte contractility was increased by 125% (p<0.01, Table 2 ). It was found that the rate of contraction increased by 90-130%, while the levels of Ai-adenosine receptors increased by 28% and 47% following 3 and 4 days of treatment, respectively, with dibutyryl cAMP at a concentration of 100 μΜ ( 
DISCUSSION
In this study we investigated the dynamic properties of A r adenosine receptors in intact rat cardiomyocytes in culture, following sustained treatment with either the adenosine antagonist Theo or the second messenger cAMP. The main finding is that there is a direct linear correlation between the cardiac contractile rate and the density of Ai-adenosine receptor antagonist binding sites (R=0.941). We showed an increase of 47-235% in [ 3 H]CPX binding (B max ) with no significant change in the affinity of the radioligand at the receptors (IQ) upon exposure of the cardiocytes to Theo for 3-5 days (Figs. 1-2) . Furthermore, this treatment caused no significant changes in CK activity, protein content and cell number (Table 1) . These findings are in agreement with results obtained by others, in which Theo was administrated orally to guinea-pigs III or rats 111/. In those studies the Ai receptors were assayed using radioligand binding in cardiocyte membrane preparations rather than in intact cells, as in our study. As in the present study up-regulation of the Ai-adenosine receptor density without any significant change in affinity was reported ΙΙ,ΙΊI. Previous studies have demonstrated that Ai-adenosine receptors in fat, brain and other tissues may be up-or down-regulated following chronic drug treatment. Adenosine receptor density increases with chronic blockade by antagonists /21,24/, and decreases with chronic stimulation of the receptors by agonists /32-35Λ We have shown in a previous study /27/ that norepinephrine, isoproterenol and thyroid hormones, which accelerate heart contraction rate, caused elevations in the receptor levels, whereas carbamylcholine, which attenuates the rate of contractions, reduced the level of adenosine receptors. In the present study chronic exposure to the antagonist Theo, which also stimulates the contractions of the cardiocytes, caused up-regulation of the Aj receptors which was also accompanied by an increased rate of contraction in the cultures (Fig. 3) . Similar results were obtained by Liang and Donovan 1261, who measured 33-51% increases in the receptor density as demonstrated in competition experiments of We have shown previously that increases in Ai receptor levels following drug treatment are time-dependent Ι2ΊΙ. Also, in our present experiments the influence of Theo and cAMP was time-dependent. For example, the significant increase in Ai receptors following an exposure to Theo or cAMP for 3 or 4 days was not seen after 2 days. The difference between our results and those of Liang and Donovan /26/ (increase of 33-51%) may be related to species differences (chick atrial cardiomyocytes), and to the duration of exposure to the drug, or to the binding technique, i.e. either in intact cells (this study) or in membrane preparations 1261. Moreover, washing of the cells after Theo treatment might influence the levels of ligand binding. It was reported that Theo induced adenosine production in canine myocardium /38/. Therefore, an intensive washing of the cells is needed before the radioligand binding assay. Although we replaced the culture medium daily during the Theo treatment, it is possible that the degree of up-regulation that was achieved in this study was hampered by the adenosine released from the cells.
It is possible that the changes observed in the levels of Ai receptors are related to changes in concentration of cAMP and not to cardiac contractions. Indeed direct application of cAMP caused an increase of Ai receptors (Figs. 4 and 5) . However, an increase in adenosine receptors was obtained with Theo at 100 μΜ or below. At these concentrations Theo exerts minimal inhibitory effects on phosphodiesterase, less than 5% /39,40/. Hence, the increased heart rate and [
3 H]CPX binding in 0.1-10 μΜ Theo (Fig. 2) is probably not a result of elevation in intracellular cAMP through phosphodiesterase inhibition. Furthermore, when the cardiocytes were treated with T 3 for 48 h, the basal level of cAMP was only 10% higher than the control, an insignificant difference /29/, whereas the level of adenosine receptors was elevated by 56% /41/. These results support our proposal that contractile activity plays a major role in regulation of adenosine receptor level, although the possibility that cAMP influences this process is not excluded.
The elevation of Ai-adenosine receptors in rat cultures after chronic Theo treatment might be reflected by increased sensitivity to adenosine linked to functional responses, that included negative chronotropic, dromotropic and inotropic effects on the heart III. Thus, up-regulation of the adenosine receptors following Theo treatment might act as an adaptive, compensatory process to return the heart to normal contractile activity and induce a homeostatic situation in the stimulated heart. As was mentioned earlier, up-regulation of Ai receptors was also induced by thyroid hormones and by catecholamines /27,41/. These hormones also induce increases in heart rate. It seems that the effects and the mechanisms that cause Theo to sensitize the receptors are similar to those in hyperthyroidism or in stress conditions such as ischemia or hypoxia, in which the levels of catecholamines increase. 
